Biodesix第四季度每股收益$(0.06)好于预期$(0.07),销售额$20.43M好于预期$19.88M

财报速递2025-03-04
Biodesix (NASDAQ:BDSX) 报告季度每股亏损$(0.06),好于分析师一致预期$(0.07),增长14.29%。 这比去年同期每股亏损$(0.10)增加了40%。 公司报告季度销售额为$20.43百万,好于分析师一致预期的$19.88百万,增长2.75%。 这比去年同期的销售额$14.67百万增加了39.28%。

以上内容来自Benzinga Earnings专栏,原文如下:

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 40 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $20.43 million which beat the analyst consensus estimate of $19.88 million by 2.75 percent. This is a 39.28 percent increase over sales of $14.67 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法